AHCO vs. RDNT, BTSG, SHC, PRVA, SGRY, CON, VCYT, LFST, ARDT, and ADUS
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Veracyte (VCYT), LifeStance Health Group (LFST), Ardent Health Partners (ARDT), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry.
AdaptHealth vs.
AdaptHealth (NASDAQ:AHCO) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, community ranking, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.
82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 1.6% of AdaptHealth shares are held by insiders. Comparatively, 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, RadNet had 9 more articles in the media than AdaptHealth. MarketBeat recorded 13 mentions for RadNet and 4 mentions for AdaptHealth. RadNet's average media sentiment score of 0.87 beat AdaptHealth's score of 0.44 indicating that RadNet is being referred to more favorably in the news media.
RadNet has lower revenue, but higher earnings than AdaptHealth. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
RadNet has a net margin of -0.25% compared to AdaptHealth's net margin of -6.57%. AdaptHealth's return on equity of 9.62% beat RadNet's return on equity.
AdaptHealth presently has a consensus price target of $13.40, indicating a potential upside of 51.41%. RadNet has a consensus price target of $69.75, indicating a potential upside of 21.55%. Given AdaptHealth's higher possible upside, analysts plainly believe AdaptHealth is more favorable than RadNet.
AdaptHealth has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.
RadNet received 266 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.17% of users gave RadNet an outperform vote while only 62.94% of users gave AdaptHealth an outperform vote.
Summary
RadNet beats AdaptHealth on 10 of the 19 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
This page (NASDAQ:AHCO) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy AHCO Stock Free AHCO Stock Alerts